skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


This content will become publicly available on September 15, 2026

Title: Synthesis of shape‐controlled silica nanoparticles via dual soft templates: A comparative study between aqueous and microemulsion synthesis for the impregnation of procaine anaesthesia drug
Abstract Silica nanoparticles (SiNPs) are promising drug delivery nanocarriers due to their tunable size, porous structure, and surface properties. This study compares two synthesis methods: (i) a low‐temperature aqueous sol–gel process yielding SiNPs of 500–700 nm, and (ii) a water‐in‐oil (W/O) microemulsion using either CTAB or TX‐100 surfactants. Surfactant selection significantly affected nanoparticle size, stability, and dispersity. Characterization by dynamic light scattering (DLS), scanning electron microscopy (SEM), X‐ray diffraction (XRD), Brunauer–Emmett–Teller (BET), solid‐state nuclear magnetic resonance spectroscopy (ssNMR), X‐ray photoelectron spectroscopy (XPS), and photoluminescence analysis (PL) confirmed successful synthesis. The TX‐100‐mediated microemulsion method proved particularly effective in achieving highly stable, reproducible, and monodisperse SiNPs, with a size limit of approximately 100 nm, making them ideal candidates for drug encapsulation. Procaine (PRC) incorporation demonstrated the role of reverse micelle dynamics and surfactant‐stabilized interfaces in enhancing encapsulation efficiency. This work highlights the critical role of surfactant and medium selection in SiNPs synthesis, demonstrating their impact on nanoparticle stability, dispersity, and drug loading efficiency. The TX‐100‐mediated microemulsion technique emerges as a superior approach for producing stable, monodisperse SiNPs, advancing the design of nanocarriers for PRC drug delivery applications.  more » « less
Award ID(s):
2308660
PAR ID:
10648566
Author(s) / Creator(s):
 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  
Publisher / Repository:
Wiley
Date Published:
Journal Name:
The Canadian Journal of Chemical Engineering
ISSN:
0008-4034
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. The blood–brain barrier (BBB) is a main obstacle for drug delivery targeting the central nervous system (CNS) and treating Alzheimer's disease (AD). In order to enhance the efficiency of drug delivery without harming the BBB integrity, nanoparticle-mediated drug delivery has become a popular therapeutic strategy. Carbon dots (CDs) are one of the most promising and novel nanocarriers. In this study, amphiphilic yellow-emissive CDs (Y-CDs) were synthesized with an ultrasonication-mediated methodology using citric acid and o -phenylenediamine with a size of 3 nm that emit an excitation-independent yellow photoluminescence (PL). The content of primary amine and carboxyl groups on CDs was measured as 6.12 × 10 −5 and 8.13 × 10 −3 mmol mg −1 , respectively, indicating the potential for small-molecule drug loading through bioconjugation. Confocal image analyses revealed that Y-CDs crossed the BBB of 5-day old wild-type zebrafish, most probably by passive diffusion due to the amphiphilicity of Y-CDs. And the amphiphilicity and BBB penetration ability didn't change when Y-CDs were coated with different hydrophilic molecules. Furthermore, Y-CDs were observed to enter cells to inhibit the overexpression of human amyloid precursor protein (APP) and β-amyloid (Aβ) which is a major factor responsible for AD pathology. Therefore, data suggest that Y-CDs have a great potential as nontoxic nanocarriers for drug delivery towards the CNS as well as a promising inhibiting agent of Aβ-related pathology of the AD. 
    more » « less
  2. Abstract Nanocarrier and exosome encapsulation has been found to significantly increase the efficacy of targeted drug delivery while also minimizing unwanted side effects. However, the development of exosome-encapsulated drug nanocarriers is limited by low drug loading efficiencies and/or complex, time-consuming drug loading processes. Herein, we have developed an acoustofluidic device that simultaneously performs both drug loading and exosome encapsulation. By synergistically leveraging the acoustic radiation force, acoustic microstreaming, and shear stresses in a rotating droplet, the concentration, and fusion of exosomes, drugs, and porous silica nanoparticles is achieved. The final product consists of drug-loaded silica nanocarriers that are encased within an exosomal membrane. The drug loading efficiency is significantly improved, with nearly 30% of the free drug (e.g., doxorubicin) molecules loaded into the nanocarriers. Furthermore, this acoustofluidic drug loading system circumvents the need for complex chemical modification, allowing drug loading and encapsulation to be completed within a matter of minutes. These exosome-encapsulated nanocarriers exhibit excellent efficiency in intracellular transport and are capable of significantly inhibiting tumor cell proliferation. By utilizing physical forces to rapidly generate hybrid nanocarriers, this acoustofluidic drug loading platform wields the potential to significantly impact innovation in both drug delivery research and applications. 
    more » « less
  3. Achieving reversible and tunable assembly of silica nanoparticles at liquid–liquid interfaces is vital for a wide range of scientific and technological applications including sustainable subsurface energy applications, catalysis, drug delivery and material synthesis. In this study, we report the mechanisms controlling the assembly of silica nanoparticles (dia. 50 nm and 100 nm) at water–heptane and water–toluene interfaces using sodium dodecyl sulfate (SDS) surfactant with concentrations ranging from 0.001–0.1 wt% using operando ultrasmall/small-angle X-ray scattering, cryogenic scanning electron microscopy imaging and classical molecular dynamics simulations. The results show that the assembly of silica nanoparticles at water–hydrocarbon interfaces can be tuned by controlling the concentrations of SDS. Silica nanoparticles are found to: (a) dominate the interfaces in the absence of interfacial SDS molecules, (b) coexist with SDS at the interfaces at low surfactant concentration of 0.001 wt% and (c) migrate toward the aqueous phase at a high SDS concentration of 0.1 wt%. Energetic analyses suggest that the van der Waals and electrostatic interactions between silica nanoparticles and SDS surfactants increase with SDS concentration. However, the favorable van der Waals and electrostatic interactions between the silica nanoparticles and toluene or heptane decrease with increasing SDS concentration. As a result, the silica nanoparticles migrate away from the water–hydrocarbon interface and towards bulk water at higher SDS concentrations. These calibrated investigations reveal the mechanistic basis for tuning silica nanoparticle assembly at complex interfaces. 
    more » « less
  4. This review examines three aspects of hexagonal boron nitride (h-BN) nanomaterials: properties, synthesis methods, and biomedical applications. We focus the scope of review on three types of h-BN nanostructures: boron nitride nanosheets (BNNSs, few-layered h-BN, larger than ∼100 nm in lateral dimensions), boron nitride quantum dots (BN QDs, smaller than ∼10 nm in all dimensions, with inherent excitation-dependent fluorescence), and boron nitride dots (BN dots, smaller than ∼10 nm in all dimensions, wide bandgap without noise fluorescence). The synthesis methods of BNNSs, BN QDs, and BN dots are summarized in top-down and bottom-up approaches. Future synthesis research should focus on the scalability and the quality of the products, which are essential for reproducible applications. Regarding biomedical applications, BNNSs were used as nanocarriers for drug delivery, mechanical reinforcements (bone tissue engineering), and antibacterial applications. BN QDs are still limited for non-specific bioimaging applications. BN dots are used for the small dimension to construct high-brightness probes (HBPs) for gene sequence detections inside cells. To differentiate from other two-dimensional materials, future applications should focus on using the unique properties of BN nanostructures, such as piezoelectricity, boron neutron capture therapy (BNCT), and their electrically insulating and optically transparent nature. Examples would be combining BNCT and chemo drug delivery using BNNSs, and using BN dots to form HBPs with enhanced fluorescence by preventing fluorescence quenching using electrically insulating BN dots. 
    more » « less
  5. Ionically complexed nanoparticles were prepared from an anionic polysaccharide drug, heparin, entrapped by a positively charged chitosan polysaccharide. In this study, the encapsulation of heparin was studied to optimize properties needed for its oral drug delivery. Chitosan, used in a variety of biomedical applications, was selected as a cationic polymer for heparin encapsulation. These particles were prepared with a slightly positive charge and an appropriate size for oral drug delivery. The release profiles of these ionically complexed nanoparticles were improved by using FDA approved stabilizers, such as pluronic non-ionic surfactant and polyvinyl alcohol. These results obtained in vitro suggest that these stabilized, ionically complexed nanoparticles may be well-suited for the oral drug delivery of heparin into the gastrointestinal tract. 
    more » « less